386 related articles for article (PubMed ID: 15679123)
21. Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.
Kemp EH; Gavalas NG; Gawkrodger DJ; Weetman AP
Autoimmun Rev; 2007 Jan; 6(3):138-42. PubMed ID: 17289548
[TBL] [Abstract][Full Text] [Related]
22. Vogt-Koyanagi-Harada disease and vitiligo: where does the illness begin?
Prignano F; Betts CM; Lotti T
J Electron Microsc (Tokyo); 2008 Jan; 57(1):25-31. PubMed ID: 18174263
[TBL] [Abstract][Full Text] [Related]
23. Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo.
Ben Ahmed M; Zaraa I; Rekik R; Elbeldi-Ferchiou A; Kourda N; Belhadj Hmida N; Abdeladhim M; Karoui O; Ben Osman A; Mokni M; Louzir H
Pigment Cell Melanoma Res; 2012 Jan; 25(1):99-109. PubMed ID: 21985183
[TBL] [Abstract][Full Text] [Related]
24. An immunohistological study of cutaneous lymphocytes in vitiligo.
Badri AM; Todd PM; Garioch JJ; Gudgeon JE; Stewart DG; Goudie RB
J Pathol; 1993 Jun; 170(2):149-55. PubMed ID: 8345407
[TBL] [Abstract][Full Text] [Related]
25. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
26. Immunopathogenesis of vitiligo.
Sandoval-Cruz M; García-Carrasco M; Sánchez-Porras R; Mendoza-Pinto C; Jiménez-Hernández M; Munguía-Realpozo P; Ruiz-Argüelles A
Autoimmun Rev; 2011 Oct; 10(12):762-5. PubMed ID: 21334464
[TBL] [Abstract][Full Text] [Related]
27. Physiopathology and genetics of vitiligo.
Passeron T; Ortonne JP
J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
[TBL] [Abstract][Full Text] [Related]
28. Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation.
Krasteva M; Kehren J; Horand F; Akiba H; Choquet G; Ducluzeau MT; Tédone R; Garrigue JL; Kaiserlian D; Nicolas JF
J Immunol; 1998 Feb; 160(3):1181-90. PubMed ID: 9570532
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
[TBL] [Abstract][Full Text] [Related]
30. Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo.
Gross A; Tapia FJ; Mosca W; Perez RM; Briceño L; Henriquez JJ; Convit J
Histol Histopathol; 1987 Jul; 2(3):277-83. PubMed ID: 2980730
[TBL] [Abstract][Full Text] [Related]
31. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo.
al Badri AM; Foulis AK; Todd PM; Gariouch JJ; Gudgeon JE; Stewart DG; Gracie JA; Goudie RB
J Pathol; 1993 Feb; 169(2):203-6. PubMed ID: 8095298
[TBL] [Abstract][Full Text] [Related]
32. Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo.
Yang L; Wei Y; Sun Y; Shi W; Yang J; Zhu L; Li M
Acta Derm Venereol; 2015 Jul; 95(6):664-70. PubMed ID: 25721262
[TBL] [Abstract][Full Text] [Related]
33. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo.
Ogg GS; Rod Dunbar P; Romero P; Chen JL; Cerundolo V
J Exp Med; 1998 Sep; 188(6):1203-8. PubMed ID: 9743539
[TBL] [Abstract][Full Text] [Related]
34. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
Dalloul AH; Ngo K; Fung-Leung WP
Eur J Immunol; 1996 Jan; 26(1):213-8. PubMed ID: 8566069
[TBL] [Abstract][Full Text] [Related]
35. Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo.
Uchi H; Stan R; Turk MJ; Engelhorn ME; Rizzuto GA; Goldberg SM; Wolchok JD; Houghton AN
Adv Immunol; 2006; 90():215-41. PubMed ID: 16730265
[TBL] [Abstract][Full Text] [Related]
36. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells.
Kumar V; Sercarz E
J Immunol; 1998 Dec; 161(12):6585-91. PubMed ID: 9862685
[TBL] [Abstract][Full Text] [Related]
37. Vitiligo, reactive oxygen species and T-cells.
Glassman SJ
Clin Sci (Lond); 2011 Feb; 120(3):99-120. PubMed ID: 20958268
[TBL] [Abstract][Full Text] [Related]
38. Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells.
De Bueger M; Bakker A; Van Rood JJ; Goulmy E
Eur J Immunol; 1991 Nov; 21(11):2839-44. PubMed ID: 1682155
[TBL] [Abstract][Full Text] [Related]
39. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
40. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells.
Buller RM; Holmes KL; Hügin A; Frederickson TN; Morse HC
Nature; 1987 Jul 2-8; 328(6125):77-9. PubMed ID: 2955227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
